Incannex Healthcare Inc (IXHL) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Mar 31 2025 - CSIMarket
CSIMarket
 


Incannex Healthcare Inc  (NASDAQ: IXHL)


Incannex Healthcare Inc's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Incannex Healthcare Inc's ROI in the fourth quarter of 2026?
Incannex Healthcare Inc recorded a cumulative net loss of $-18 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on investment (ROI) of -30.08%.

Within the Healthcare sector 371 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2026 from 3084 to 3683.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
IV. Quarter
(Mar 31 2026)
III. Quarter
(Dec 31 2025)
II. Quarter
(Jun 30 2025)
IV. Quarter
(Mar 31 2025)
III. Quarter
Y / Y Investment Change TTM 491.62 % 243.49 % 52.8 % -52.78 % -56.95 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 71 78 73 13 9
Return On Investment (TTM) -30.08 % -44.31 % -84.28 % -35.86 % -46.2 %
IXHL's Overall Ranking # 3683 # 3084 # 2981 # 0 #
Seq. Investment Change TTM 36 % 72.24 % 159.02 % -2.49 % -21.04 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -18 -19 -21 -3 -5




Return On Investment IXHL's Ranking
Within: No.
Industry # 146
Sector # 372
Overall # 3683

Return On Investment Statistics
High Average Low
-30.08 %
-55.41 %
-109.34 %
(Jun 30 2026)   (Dec 31 2023)







Financial Statements
Incannex Healthcare Inc's IV. Quarter Investments $ 71 Millions IXHL's Balance sheet
Incannex Healthcare Inc's IV. Quarter Income $ -2 Millions Quarterly IXHL's Income Statement
IXHL's Income by Division See IXHL's Income by Division


IXHL Annual Return On Investment (Jun 30 2026)
2026
(Sep 30 2025)
2025
(Sep 30 2024)
2024
(Jun 30 2023)
2023
(Jun 30 2020)
2022
Total Investments in Millions 71 77 7 19 28
Y / Y Investment Growth -7.25 % 1030.75 % -65.02 % -30.18 % -
Net Income in Millions -19 -6 -5 -20 -15
Y / Y Net Income Growth - - - - -
Annual Return On Investment -27 % -8.31 % -79.52 % -102.52 % -53.39 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IXHL's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IXHL's Competitors
Subscribers only: Roi for Incannex Healthcare Inc's Suppliers
Subscribers only: Return On Investment for IXHL's Customers

Other Ratios
IXHL's Roa IXHL's Inventory Turnover Ratio IXHL's Growth Rates IXHL's Dividend Statistics
IXHL's Profitability Ratios IXHL's Asset Turnover Ratio IXHL's Dividend Growth
IXHL's Roe IXHL's Valuation Ratios IXHL's Financial Strength Ratios IXHL's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-26T05:09:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.